3 min read

Barings BDC: Developments At Pharmaceutical Portfolio Company

A troubled pharmaceutical manufacturer in which Barings BDC is invested has made huge strides in resolving its difficulties in the past two days. We re-publish two articles from the BDC Credit Reporter that bring the situation up to date.

This post is for paying subscribers only